Facebook
Twitter
LinkedIn
ForwardMiami Cancer Institute: Innovations in the Management of Pancreatic Cancer
Pancreatic cancer is one of the most lethal diseases and could be the second leading cause of cancer death in the United States by 2020. Surgical resection offers the only potential for cure; however, most patients are diagnosed in the later stages when the disease is unresectable. Systemic chemotherapy is the mainstay for the management of patients with pancreatic cancer, but it has limited efficacy. Recent advances in surgery, radiation therapy, ablative options, and endovascular therapies have brought promise and hope to these patients.
In this course, a multidisciplinary panel of experts examine recently published trial data, novel systemic therapies, MR-guided radiation therapy, minimally invasive approaches to pancreatic surgery, irreversible electroporation (IRE) for pancreatic cancer, and more.
Target Audience
Radiation Oncologists, Medical Oncologists, Oncology Surgeons, Radiologists, Internists, Hospitalists, General Practitioners, Gastroenterologists, General Surgeons, Obstetricians and Gynecologists, Medical Oncologists, Nurses, Social Workers, Patient Navigators and all other interested healthcare professionals.
Learning Objectives
- Assess patient selection for surgery versus nonsurgical ablative therapies for pancreatic cancer patients.
- Implement approaches of selection of systemic therapies for pancreatic cancer patients.
- Compare differences between local ablative therapies for patients with unresectable pancreatic cancer.
Faculty
Domenech Asbun, M.D.
Hepatobiliary and Pancreatic Surgeon
Miami Cancer Institute
Miami, Florida
Michael Chuong, M.D., FACRO
Radiation Oncologist
Vice Chair and Medical Director of Radiation Oncology
Leads G.I. Radiation Services at Baptist Health
Miami Cancer Institute
Miami, Florida
Govindarajan Narayanan, M.D.
Interventional Oncologist
Miami Cancer Institute
Miami, Florida
Antonio Ucar, M.D.
Medical Oncologist
Miami Cancer Institute
Miami, Florida
Domenech Asbun, M.D., faculty of this educational activity is a consultant for Stryker and has received financial support from Boston Scientific. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Michael Chuong, M.D., faculty of this educational activity has received grant/research support from ViewRay, Novocure and StratPharma. He holds an executive role with a proton collaborative group and is on the speaker’s bureau for ViewRay. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Govindarajan Narayanan, M.D., faculty of this educational activity is a consultant for Angiodynamics, Styker, Varian International Solutions and Philips. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Antonio Ucar, M.D., faculty of this educational activity has no relevant financial relationships with ineligible companies to disclose and has indicated that the presentation or discussion does not include off-label or unapproved product usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Surgery - Accredited CME - Complex General Surgical Oncology
Successful completion of this CME activity enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Available Credit
- 1.25 ABS MOC II
- 1.25 AMA PRA Category 1 Credit™
- 1.25 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Required Hardware/Software
PC/Mac Users
This site is supported on the most recent stable releases of the following browsers:
Google Chrome
Microsoft Edge
Safari
Mozilla Firefox
Mobile Users
This site is supported on the following mobile devices:
- Apple iOS mobile devices running iOS 10 or later
- Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.